Cladribine - an old newcomer for pulsed immune reconstitution in MS
- PMID: 28884753
- DOI: 10.1038/nrneurol.2017.119
Cladribine - an old newcomer for pulsed immune reconstitution in MS
Abstract
The EMA has approved cladribine tablets for the treatment of multiple sclerosis. The drug is not new, and the journey to its approval has been a long one, but the old concepts that cladribine therapy are based on provide a new option for the possibility of drug-free remission.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
